<DOC>
	<DOCNO>NCT00139256</DOCNO>
	<brief_summary>This randomize , multicenter , double blind , placebo control trial betamethasone versus placebo give prior mother term near term gestation ( &gt; 34 &lt; 40 week gestation ) schedule undergo plan Cesarean section . The study design determine efficacy safety betamethasone prevention breathe problem commonly see population . In infant born elective Cesarean section , hypothesize antenatal betamethasone treatment reduce risk neonatal intensive care unit ( NICU ) admission 11 % 8 % and/or oxygen therapy +/- positive pressure ventilation ( PPV ) &gt; 30 minute 4.5 % 2.5 % .</brief_summary>
	<brief_title>Antepartum Betamethasone Treatment Prevention Respiratory Distress Infants Born Elective Cesarean Section</brief_title>
	<detailed_description>The purpose pilot study determine antepartum betamethasone give mother undergo elective cesarean section ( ECS ) delivery term near term gestation ( &gt; 34 &lt; 40 week gestation ) safe feasible reduce neonatal respiratory morbidity relate admission neonatal intensive care unit ( NICU ) . The data pilot study use support NIH application multicenter randomize trial determine , compare placebo treatment , antenatal betamethasone initiate 2-7 day prior ECS result decrease occurrence respiratory morbidity NICU admission newborn . The multicenter protocol recently review NICHD network clinical trial . The reviewer enthusiastic scientific merit public health importance study ask pilot study determine feasibility launch national trial . Given rise rate CS delivery , project substantial health cost saving preventive strategy find successful reduce neonatal morbidity .</detailed_description>
	<mesh_term>Respiratory Distress Syndrome , Newborn</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Adult</mesh_term>
	<mesh_term>Betamethasone benzoate</mesh_term>
	<mesh_term>Betamethasone-17,21-dipropionate</mesh_term>
	<mesh_term>Betamethasone</mesh_term>
	<mesh_term>Betamethasone Valerate</mesh_term>
	<mesh_term>Betamethasone sodium phosphate</mesh_term>
	<criteria>Pregnant woman &gt; /= 34 week gestation schedule undergo operative delivery within 4872 hour study enrollment Known contraindication use betamethasone mother Known lethal nonlethal congenital anomaly diagnose antenatally Spontaneous labor Premature rupture membrane</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Glucocorticoid</keyword>
	<keyword>Antepartum Betamethasone Treatment</keyword>
	<keyword>Elective Cesarean Section</keyword>
	<keyword>Respiratory Distress Infants</keyword>
</DOC>